MET and cancer: Picomolar activity against cancer cell lines from various solid tumors, including lung, colorectal, and gastric cancers, was exhibited by this nonagonistic c-MET antibody linked to the pyrrolobenzodiazepine (PBD) toxin-linker tesirine.